Skip to content

Apyx Medical Corporation APYX Q4 2024 Annual earnings

Reported March 13, 2025 · Before market open

Revenue$14.2MBeat by $4.3M
EPS-$0.12Beat by $0.01
Revenue estimate$9.9M
EPS estimate-$0.13

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$13.2M
EPS estimate-$0.06

Financials

Q4 2024

Income statement

See full
Revenue$14.2M-3.0%
Net income-$4.7M+51.5%

Balance sheet

See full
Cash & equivalents$31.7M-27.3%
Total debt$38.8M+0.7%
Total equity$14.2M-46.8%
Total assets$64.8M-18.2%

Cash flow

See full
Operating cash flow-$2.9M-32.8%
CapEx$245.0K+163%
Free cash flow-$3.2M-38.0%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$59.48M-34.5%
Enterprise value$66.52M-22.3%
P/S1.2×-0.5×

Profitability

See full
Net margin-48.9%+28.4pp
FCF margin-39%

Returns & leverage

See full
Return on equity-115%+4,394pp
Debt / equity2.7×+1.3×
Current ratio5.3×-0.3×

Segments

By segment

See full
Oem$2.1M-16.0%

Versus estimates

Ask the moment Apyx Medical Corporation reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Apyx Medical Corporation report Q4 2024 earnings?
Apyx Medical Corporation (APYX) reported Q4 2024 earnings on March 13, 2025 before market open.
What were Apyx Medical Corporation's Q4 2024 revenue and EPS?
Apyx Medical Corporation reported revenue of $14.2M and eps of $-0.12 for Q4 2024.
Did Apyx Medical Corporation beat estimates in Q4 2024?
Revenue beat the consensus estimate of $9.9M by $4.3M. EPS beat the consensus estimate of $-0.13 by $0.01.
Where can I find Apyx Medical Corporation's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001437749-25-007521) directly on SEC EDGAR. The filing index links above go to sec.gov.